Location History:
- Latham, NY (US) (2009 - 2012)
- Ellicott City, MD (US) (2014 - 2019)
Company Filing History:
11 out of 35 
2 out of 17,173 
2 out of 39 
Years Active: 2009-2019
Title: Kande K D Amarasinghe: Innovator in Protein Tyrosine Phosphatase Inhibitors
Introduction
Kande K D Amarasinghe is a notable inventor based in Latham, NY (US). He has made significant contributions to the field of biochemistry, particularly in the development of human protein tyrosine phosphatase inhibitors. With a total of 16 patents to his name, Amarasinghe's work has the potential to impact various therapeutic applications.
Latest Patents
Amarasinghe's latest patents focus on human protein tyrosine phosphatase beta (HPTP-β) inhibitors. These compounds are designed to regulate angiogenesis, which is crucial for various biological processes. The patents detail compositions that include these inhibitors and methods for their use in regulating angiogenesis.
Career Highlights
Throughout his career, Amarasinghe has worked with prominent companies such as Aerpio Therapeutics, Inc. and The Procter & Gamble Company. His experience in these organizations has allowed him to refine his expertise in the development of innovative therapeutic solutions.
Collaborations
Amarasinghe has collaborated with notable professionals in his field, including Jeffrey Lyle Gray and Cynthia Monesa Clark. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Kande K D Amarasinghe is a distinguished inventor whose work in protein tyrosine phosphatase inhibitors showcases his commitment to advancing medical science. His contributions have the potential to lead to significant breakthroughs in therapeutic applications.